US EditionAstraZeneca to withdraw COVID vaccine globally as demand dips
- AstraZeneca reported a decrease in demand for the Vaxzevria vaccine due to the availability of new Covid variant-specific vaccines.
- Multiple COVID-19 vaccines tailored to specific variants have led to Vaxzervria not being manufactured or supplied anymore.
- AstraZeneca announced the global withdrawal of its COVID-19 vaccine on May 7, citing excess availability of updated vaccines.
244 Articles
244 Articles
The British pharmaceutical giant AstraZeneca announced on Wednesday that it is withdrawing from sale its vaccine against Covid-19 Vaxzevria, one of the first to be released during the pandemic, due to the drop in demand. “Considering that multiple vaccines have been developed against Covid-19, there is an excess of updated vaccines” in the face of the different variants of the virus, “which translates into a drop in demand for Vaxzevria, which i…
Confessed recently for the first time lethal side effects. Claims that the time is a coincidence.
AstraZeneca Initiates Global Withdrawal of COVID-19 Vaccine Due to Rare Side Effects
El gigante farmac�utico brit�nico AstraZeneca anunci� que retira de la venta su vacuna contra el Covid-19 por la bajada en la demanda.
Coverage Details
Bias Distribution
- 46% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
